SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-016177
Filing Date
2023-05-10
Accepted
2023-05-10 16:27:39
Documents
16
Period of Report
2023-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48044
2 ex10-1.htm EX-10.1 29934
3 ex99-1.htm EX-99.1 50778
4 ex99-1_001.jpg GRAPHIC 4015
  Complete submission text file 0001493152-23-016177.txt   371656

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cing-20230509.xsd EX-101.SCH 3986
6 XBRL DEFINITION FILE cing-20230509_def.xml EX-101.DEF 26635
7 XBRL LABEL FILE cing-20230509_lab.xml EX-101.LAB 36718
8 XBRL PRESENTATION FILE cing-20230509_pre.xml EX-101.PRE 25259
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5470
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 23906910
SIC: 2834 Pharmaceutical Preparations